The State of Venture

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Analyst reports trendsetting biotech breakthroughs

Artificial intelligence a key challenge for Germany's next government

Biopharma Collaboration Is Key For Innovation

Artificial Intelligence In Drug Discovery

Deloitte reports biopharma prioritizes AI investment

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”